C. difficile infection recurrence after FMT higher than previously reported in IBD

CHICAGO — More than 20% of patients with inflammatory bowel disease experienced recurrent Clostridioides difficile infection 1 year after fecal microbiota transplantation, according to data presented at Digestive Disease Week.
“While there are data on the short-term efficacy of FMT for eradicating C. diff infections in patients with IBD, there is less known about longer-term

Related Keywords

Chicago ,Illinois ,United States ,Celgene Receptos ,Heather Biele ,Edwardv Loftus Jr ,Bymonica Stonehill ,Edward Loftus ,Bristol Myers Squibb ,Amgen ,Pfizer ,Genentech ,Digestive Disease Week ,Celltrion Healthcare ,Gossamer Bio ,Iterative Scopes ,Digestive Disease ,Jack Zarrow Family Professor ,Mayo Clinic ,